Impact of Early Intervention in Fabry's Disease

This chapter analyzes a study on 60 patients with Fabry's disease, emphasizing the critical role of early enzyme replacement therapy in preventing disease progression, particularly left ventricular hypertrophy (LVH). It also explores sex differences in disease advancement and highlights the potential benefits of timely interventions for specific age groups, along with the promise of gene therapy and advanced diagnostics.